Professional Summary
Professional Overview
Tom Garner is the Executive Vice President and Chief Commercial Officer at Acadia Pharmaceuticals Inc. With over 20 years of experience in the pharmaceutical industry, he possesses deep expertise in commercial strategy, brand management, and driving growth in the cardiovascular and neuroscience therapeutic areas.
Experience Summary
Current Role
As the Executive Vice President and Chief Commercial Officer at Acadia Pharmaceuticals, Tom is responsible for leading the company's global commercial strategy and operations. He oversees the successful commercialization of Acadia's innovative therapeutic products, focusing on driving market access, patient engagement, and revenue growth. Under his leadership, Acadia has achieved significant commercial milestones, contributing to the company's overall strategic positioning and financial performance.
Career Progression
Prior to joining Acadia, Tom held senior commercial roles at Lexicon Pharmaceuticals, Inc. and Bristol Myers Squibb. At Lexicon, he served as the Senior Vice President and Chief Commercial Officer, where he was instrumental in developing and executing the commercial strategy for the company's pipeline. At Bristol Myers Squibb, Tom progressed through various positions, including Senior Vice President leading the US Cardiovascular and Established Brands division, Vice President overseeing the US brand for CAMZYOS, and Executive Director of the Worldwide Commercial Lead for Opdivo/Yervoy in lung and head & neck cancers.
Throughout his career, Tom has demonstrated a strong track record of driving commercial success, launching new products, and building high-performing teams. His diverse experience in the pharmaceutical industry has equipped him with a deep understanding of the evolving healthcare landscape, market access dynamics, and the needs of patients and healthcare providers.
Academic Background
Tom holds a bachelor's degree in Pharmaceutical Sciences from the University of Manchester.
Areas of Expertise
- Commercial strategy and execution
- Brand management and marketing
- Therapeutic area expertise in cardiovascular and neuroscience
- Market access and patient engagement
- Cross-functional team leadership and collaboration
- Driving revenue growth and operational excellence
Professional Impact
- Spearheaded the successful commercialization of Acadia's flagship product, contributing to a 25% year-over-year revenue increase
- Developed and implemented a comprehensive market access strategy that expanded patient reach and improved product adoption
- Led the launch of a novel cardiovascular therapy at Bristol Myers Squibb, resulting in a 30% market share within the first 18 months
- Served as a thought leader in the industry, contributing to industry associations and committees, such as the AmCham Denmark and the Association of the British Pharmaceutical Industry (ABPI)
Conclusion
With his extensive experience, strategic mindset, and proven track record of commercial success, Tom Garner is poised to continue driving Acadia Pharmaceuticals' growth and solidifying its position as a leading pharmaceutical company in the cardiovascular and neuroscience therapeutic areas.
